Uniqure Other Liab from 2010 to 2025

QURE Stock  USD 13.70  0.23  1.65%   
Uniqure NV's Other Liabilities is decreasing over the years with stable fluctuation. Other Liabilities is expected to dwindle to about 15.8 M. During the period from 2010 to 2025 Uniqure NV Other Liabilities annual values regression line had geometric mean of  26,575,944 and mean square error of 762 T. View All Fundamentals
 
Other Liabilities  
First Reported
2013-09-30
Previous Quarter
18.5 M
Current Value
403.8 M
Quarterly Volatility
65.3 M
 
Yuan Drop
 
Covid
Check Uniqure NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Uniqure NV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.6 M, Interest Expense of 66.9 M or Other Operating Expenses of 135.8 M, as well as many indicators such as Price To Sales Ratio of 30.1, Dividend Yield of 0.0 or Days Sales Outstanding of 156. Uniqure financial statements analysis is a perfect complement when working with Uniqure NV Valuation or Volatility modules.
  
Check out the analysis of Uniqure NV Correlation against competitors.
For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.

Latest Uniqure NV's Other Liab Growth Pattern

Below is the plot of the Other Liab of Uniqure NV over the last few years. It is Uniqure NV's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Uniqure NV's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Pretty Stable
   Other Liab   
       Timeline  

Uniqure Other Liab Regression Statistics

Arithmetic Mean35,073,571
Geometric Mean26,575,944
Coefficient Of Variation77.64
Mean Deviation21,121,893
Median22,540,000
Standard Deviation27,230,623
Sample Variance741.5T
Range90.1M
R-Value(0.20)
Mean Square Error762T
R-Squared0.04
Significance0.45
Slope(1,156,109)
Total Sum of Squares11122.6T

Uniqure Other Liab History

202515.8 M
202416.7 M
202218.5 M
202146.7 M
20203.1 M
201926.7 M
201838.9 M

About Uniqure NV Financial Statements

Uniqure NV stakeholders use historical fundamental indicators, such as Uniqure NV's Other Liab, to determine how well the company is positioned to perform in the future. Although Uniqure NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in Uniqure NV's assets and liabilities are reflected in the revenues and expenses on Uniqure NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Uniqure NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities16.7 M15.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Uniqure NV is a strong investment it is important to analyze Uniqure NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Uniqure NV's future performance. For an informed investment choice regarding Uniqure Stock, refer to the following important reports:
Check out the analysis of Uniqure NV Correlation against competitors.
For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Uniqure NV. If investors know Uniqure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Uniqure NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.18)
Earnings Share
(4.92)
Revenue Per Share
0.557
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.16)
The market value of Uniqure NV is measured differently than its book value, which is the value of Uniqure that is recorded on the company's balance sheet. Investors also form their own opinion of Uniqure NV's value that differs from its market value or its book value, called intrinsic value, which is Uniqure NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Uniqure NV's market value can be influenced by many factors that don't directly affect Uniqure NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Uniqure NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Uniqure NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Uniqure NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.